Holen Sie sich die Stockscreener-App
3.40
0.58%
-0.02
Handel nachbörslich:
3.51
0.11
+3.24%
Schlusskurs vom Vortag:
$3.42
Offen:
$3.42
24-Stunden-Volumen:
40,359
Relative Volume:
0.08
Marktkapitalisierung:
$54.05M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-23.87M
KGV:
-0.1729
EPS:
-19.67
Netto-Cashflow:
$-47.63M
1W Leistung:
+0.59%
1M Leistung:
-1.16%
6M Leistung:
+16.64%
1J Leistung:
-2.56%
1-Tages-Spanne:
$3.36
$3.4955
1-Wochen-Bereich:
$3.3359
$3.52
52-Wochen-Spanne:
$2.30
$3.93
Polypid Ltd Stock (PYPD) Company Profile
Vergleichen Sie PYPD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PYPD
Polypid Ltd
|
3.40 | 54.21M | 0 | -23.87M | -47.63M | -19.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Polypid Ltd Stock (PYPD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-05 | Eingeleitet | Roth Capital | Buy |
| 2025-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-01-28 | Eingeleitet | Rodman & Renshaw | Buy |
| 2021-09-14 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-07-30 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-11-24 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2020-08-10 | Eingeleitet | Alliance Global Partners | Buy |
| 2020-07-21 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-07-21 | Eingeleitet | Barclays | Overweight |
| 2020-07-21 | Eingeleitet | Raymond James | Outperform |
Alle ansehen
Polypid Ltd Aktie (PYPD) Neueste Nachrichten
Is PolyPid Ltd.’s growth already priced inLayoff News & Precise Swing Trade Entry Alerts - khodrobank.com
What momentum shifts mean for PolyPid Ltd.Market Trend Report & Trade Opportunity Analysis - Newser
Will PolyPid Ltd. stock recover after recent dropRisk Management & Weekly Chart Analysis and Trade Guides - Newser
PolyPid to Participate in the Upcoming 27th Annual H.C. Wainwright Global Investment Conference - GlobeNewswire
Late-Stage Biopharma PolyPid Joins H.C. Wainwright Global Investment Conference for Key Presentation - Stock Titan
Statistical indicators supporting PolyPid Ltd.’s strengthCPI Data & Fast Moving Trade Plans - Newser
Is it too late to sell PolyPid Ltd.July 2025 Opening Moves & Safe Entry Zone Tips - Newser
Visual analytics tools that track PolyPid Ltd. performance2025 Momentum Check & High Win Rate Trade Alerts - Newser
How sentiment analysis helps forecast PolyPid Ltd.July 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Price momentum metrics for PolyPid Ltd. explainedGDP Growth & Weekly Market Pulse Alerts - Newser
PolyPid to Present at Israel Controlled Release Society Conference: Insights into PLEX Technology - AInvest
PolyPid Ltd. to Present at Israel Controlled Release Society Conference on Advances in Drug Delivery Technology - Quiver Quantitative
PolyPid to Present at the 14th Meeting of the Israel Controlled Release Society Conference - GlobeNewswire
Novel Drug Delivery Platform Success: PolyPid's Phase 3 Journey Takes Center Stage at ICRS Conference - Stock Titan
Long term hold vs stop loss in PolyPid Ltd.Rate Cut & Consistent Growth Stock Picks - Newser
PolyPid Ltd. stock daily chart insightsEarnings Overview Summary & Free High Return Stock Watch Alerts - Newser
Is PolyPid Ltd. stock trending bullishWeekly Trend Recap & Short-Term Trading Alerts - khodrobank.com
How to interpret RSI for PolyPid Ltd. stockM&A Rumor & AI Optimized Trade Strategies - Newser
What are the analyst revisions for PolyPid Ltd.Is IONR stock a good investment in YEAR2025 Institutional Moves & Precise Swing Trade Alerts - khodrobank.com
PolyPid Ltd. Reports Positive Q2 Earnings: Strong Balance Sheet, Successful Trials and Future Growth Plans - AInvest
Can PolyPid Ltd. ride the EV waveEarnings Recap Summary & Weekly Setup with ROI Potential - khodrobank.com
Is PolyPid Ltd. subject to activist investor interestGold Moves & Free Fast Gain Swing Trade Alerts - خودرو بانک
Is PolyPid Ltd. affected by consumer sentimentJuly 2025 Price Swings & Comprehensive Market Scan Reports - khodrobank.com
Will PolyPid Ltd. face regulatory challengesNew Guidance & Stock Portfolio Risk Control - khodrobank.com
Can PolyPid Ltd. rally from current levelsWeekly Trade Review & Expert Verified Stock Movement Alerts - Newser
PolyPid Ltd. Earnings Call: Positive Trials and Financial Strength - TipRanks
Live market analysis of PolyPid Ltd.Trade Exit Summary & AI Forecast for Swing Trade Picks - Newser
Price Floor Holding on PolyPid Ltd. — Rebound Possible getLinesFromResByArray error: size == 0 - sisain.net
PolyPid Ltd. (NASDAQ:PYPD) Receives Average Rating of “Buy” from Brokerages - Defense World
PolyPid Ltd. Stock Lags Behind Sector Benchmarks getLinesFromResByArray error: size == 0 - kangso.co.kr
What high frequency data says about PolyPid Ltd.2025 Price Targets & Long-Term Investment Growth Plans - Newser
How sentiment analysis helps forecast PolyPid Ltd2025 Geopolitical Influence & Intraday High Probability Alerts - Newser
Can technical indicators confirm PolyPid Ltd.’s reversalAnalyst Downgrade & Safe Swing Trade Setup Alerts - Newser
Custom watchlist performance reports with PolyPid Ltd.Earnings Beat & Accurate Entry and Exit Point Alerts - Newser
Finanzdaten der Polypid Ltd-Aktie (PYPD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):